Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
BETA v.3.0

2025 CPT code 58957

Resection (tumor debulking) of recurrent ovarian, tubal, primary peritoneal, uterine malignancy (intra-abdominal, retroperitoneal tumors), with omentectomy, if performed.

Follow all applicable CPT guidelines for surgical procedures.Accurate documentation is crucial for proper code assignment.

Modifiers may be applicable depending on the circumstances of the procedure (e.g., 22 for increased procedural services, 51 for multiple procedures, 59 for distinct procedural service). Consult the CPT codebook and payer guidelines for specific modifier usage.

Medical necessity for CPT 58957 is established by the presence of recurrent malignancy in the specified locations (ovaries, fallopian tubes, peritoneum, or uterus) and the expectation that cytoreductive surgery will improve the patient's prognosis by reducing tumor burden, often in preparation for adjuvant therapies.

The surgeon places the patient in the supine position and administers general anesthesia. A midline vertical incision is made to explore the abdomen, pelvis, and viscera. Adhesions are lysed, and tumors are removed from the peritoneal cavity.Further incisions may be made to access and remove tumors from the uterine vessels and ligaments. Omentectomy may be performed if necessary. The abdominal incision is closed with absorbable sutures.

IMPORTANT:For pelvic laparotomy, use 49000. For excision or destruction of endometriomas, open method, see 49203-49205, 58957, 58958. For paracentesis, see 49082, 49083, 49084. For secondary closure of abdominal wall evisceration or disruption, use 49900. For fulguration or excision of lesions, laparoscopic approach, use 58662. For chemotherapy, see 96401-96549.

In simple words: The doctor removes recurring cancer from the ovaries, fallopian tubes, or uterus through an incision in the abdomen.This may also involve removing part of the tissue surrounding the intestines. The goal is to remove as much cancer as possible.

This procedure involves the surgical removal of recurrent cancerous tumors found in the ovaries, fallopian tubes, peritoneum, or uterus.The procedure is performed via an abdominal approach. If necessary, the omentum (a membrane covering the bowel) may also be excised. The surgeon makes an incision, explores the abdominal and pelvic cavities to identify and remove as many tumors as possible.This may involve lysis of adhesions and potentially the removal of parts of the omentum, ovaries, fallopian tubes, or uterus.

Example 1: A 55-year-old female patient with a history of ovarian cancer presents with recurrent disease.A debulking procedure (CPT 58957) is performed to remove as much of the visible tumor as possible to improve the effectiveness of subsequent chemotherapy., A 48-year-old female patient with recurrent endometrial cancer involving the peritoneum undergoes a cytoreductive surgery.The surgeon performs a comprehensive resection (CPT 58957), including partial omentectomy, to remove all macroscopic disease., A 62-year-old female patient with recurrent ovarian cancer and significant peritoneal involvement undergoes a complex debulking procedure (CPT 58957).The procedure includes extensive lysis of adhesions and resection of portions of the ovaries, fallopian tubes, and omentum.

Preoperative diagnosis, operative report detailing extent of resection (including organs involved and weight of resected tissue), pathology report confirming malignancy, and any postoperative complications.Imaging studies (CT scans or MRI) to document tumor burden pre- and post-operatively may be required.

** This code is used for debulking, meaning the complete removal of the tumor may not be possible. The extent of the resection should be documented thoroughly in the operative report.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.